Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Xeris Biopharma Holdings, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
Revenues110.249.620.4
            Revenue growth122.3%142.7% 
Cost of goods sold43.613.39.3
Gross profit66.636.311.1
            Gross margin60.5%73.1%54.4%
Selling, general and administrative137.7125.773.7
Research and development 25.220.9
EBITA-71.1-114.6-83.5
            EBITA margin-64.5%-231.1%-408.8%
Amortization of intangibles10.80.6 
EBIT-81.9-115.2-83.5
            EBIT margin-74.3%-232.2%-408.8%
Pre-tax income-96.1-122.7-91.1
Income taxes-1.40.00.1
            Tax rate1.5%0.0% 
Net income-94.7-122.7-91.3
            Net margin-85.9%-247.5%-446.5%
 
Diluted EPS($0.70)($1.55)($2.14)
Shares outstanding (diluted)135.679.042.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy